| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |